GE buys genomic services CRO

By Nick Taylor

- Last updated on GMT

Related tags Dna

GE buys genomic services CRO
GE Healthcare has bought a nucleic acid technology CRO, SeqWright, to add to its range of genomic services.

Buying SeqWright gives GE new genomic services, such as nucleic acid sequencing, to complement the capabilities it acquired in the $580m (€440m) takeover of Clarient. By combining the assets GE will expand its range of diagnostic services to support the shift towards personalised medicine.

This partnership will put us in a position to apply the power of new direct detection technologies to clinical and companion diagnostics, potentially revolutionising the way healthcare decisions are made​”, Fei Lu, president and CEO of SeqWright, said.

SeqWright calls itself a full-service nucleic acid technology CRO (contract research organisation). The business was founded in 1994 by a doctor involved in the Human Genome Project and has expanded to offer GLP (good laboratory practice) support services, biomarker discovery, and DNA sequencing.

GE views sequencing as an important part of its medical diagnostics business that will complement protein and gene expression capabilities at Clarient. Buying into the sector gives GE a foothold from day one.

The acquisition of a specialised laboratory with long-standing expertise in the sequencing field as well as an established customer base allows us immediate entry into this high-growth space​”, Carrie Eglinton-Manner, CEO of Clarient, said.

A year ago SeqWright expanded its sequencing capabilities with the installation of a second Illumina HiSeq 2000 and new bioinformatics tools to increase workflow. Using the setup SeqWright cut the time taken to map next-generation sequencing runs.

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

Related suppliers

Follow us

Products

View more

Webinars